Kuala Lumpur – CCM Duopharma Biotech Berhad (CCMD) recorded an increase of 6.3 per cent in revenue to RM122.9 million for its financial year ended December 31, 2008 from RM115.6 million in the corresponding period last year.  The growth was mainly due to the increase in demand by the export and private market.

However, CCMD’s profit before tax fell to RM35.3 million from RM42.5 million in the same period.  The decline in profit before tax was attributable to an increase in raw material costs absorbed by the Group as well as once-off stocks write-off mainly due to regulatory requirements.
 
CCMD has recommended a final tax exempt dividend of 14 per cent (7.0 sen) per share. The total dividend for the current financial year is 30 per cent (15 sen) per share consists of a final tax exempt dividend of 14 per cent (7 sen) per share and an interim dividend of 16 sen (8 sen) amounting to approximately RM20.9 million.

CCM Duopharma Biotech Berhad is a subsidiary of CCM Berhad which is listed on the main board of Bursa Malaysia and is a key player in the fertilizers, chemicals and pharmaceuticals industries.

ooOoo

Issued with the compliments of Chemical Company of Malaysia Berhad
For further information, please contact: Ida Fazila Ismail
of Eric Pringle Associates Public Relations Sdn Bhd
at Tel No: 21617144 or email: ifazila@epapr.com.my